文献速递眼底病与葡萄膜炎

戊聚糖多硫酸钠黄斑病变的视觉功能评估

Visual Function in Pentosan Polysulfate Sodium Maculopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

结果显示中位ETDRS视力为82个字母(Snellen等效20/25),但NEI-VFQ-39和LLQ复合评分中位分别为65和41,暗适应杆截距时间中位14.1分钟,提示视觉功能显著下降且未被视力检查充分捕捉。结构进展期患眼多项功能指标显著更差。

要点

  • PPS黄斑病变患者虽视力较好,但患者报告视觉功能和生活质量评分明显降低。
  • 暗适应杆截距时间中位14.1分钟,提示暗适应延迟常见。
  • 视网膜结构进展期患眼多项视觉功能指标显著更差。

核心结论

  • PPS黄斑病变导致相当程度的视觉功能下降,且未被最佳矫正视力检查充分捕捉。
  • 其他视觉功能指标与疾病严重程度有良好相关性。
  • 这些发现加深了对该患者安全问题的担忧。

研究设计与样本

  • 进行多模态视网膜结构与功能评估,结构改变分为中度或进展期。
  • 患者报告视觉功能采用NEI-VFQ-39和低亮度问卷(LLQ)评估。
  • 客观功能评估包括ETDRS最佳矫正视力、Pelli-Robson对比敏感度、中间视觉微视野检查和暗适应检查。

主要发现

  • 中位ETDRS字母评分为82(Snellen等效20/25)。
  • 中位NEI-VFQ-39和LLQ复合评分分别为65(范围33-88)和41(范围20-92)。
  • 中位对比敏感度为1.65(范围0.15-1.95)。
  • 中位中间视觉微视野平均阈值和阈值降低百分比分别为26分贝(范围0.4-28.6)和21.6%(范围0-100%)。
  • 中位杆截距时间为14.1分钟(范围4.4-20.0)。

关键数值与推荐

  • 基于视网膜结构的进展期患眼在多种测试模式中视网膜功能显著更差。

临床怎么用

  • 对PPS黄斑病变患者应进行超越最佳矫正视力的全面视觉功能评估。
  • 患者报告的视觉功能问卷和暗适应检查有助于发现视力检查未捕捉的功能损害。
  • 视网膜结构进展期与更差的视觉功能相关,提示需关注疾病严重程度。

局限性

  • 原文未报告对照组或纵向随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Individuals with pentosan polysulfate sodium (PPS) maculopathy commonly report symptoms of prolonged dark adaptation and difficulty reading. We hypothesize that PPS maculopathy causes degradation of visual function not fully captured with visual acuity testing. METHODS: Subjects with PPS maculopathy underwent multimodal evaluation of retinal structure and function. Structural changes were graded as moderate or advanced. Patient-reported visual function was assessed with the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ-39) and Low Luminance Questionnaire (LLQ). Objective functional evaluations included Early Treatment of Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA), Pelli-Robson contrast sensitivity, mesopic microperimetry, and dark adaptometry. Functional testing results were correlated with structural disease category. RESULTS: Thirteen patients (26 eyes), median age 62 years (range, 37-76), completed the study. Median ETDRS letter score was 82 (Snellen equivalent 20/25). Median NEI-VFQ-39 and LLQ composite scores were 65 (range, 33-88) and 41 (range, 20-92), respectively. Median contrast sensitivity was 1.65 (range, 0.15-1.95), and median mesopic microperimetry average thresholds and percent reduced thresholds were 26 decibels (range, 0.4-28.6) and 21.6% (range, 0-100%), respectively. Median rod intercept time was 14.1 minutes (range, 4.4-20.0). Eyes with advanced disease based on retinal structure had significantly worse retinal function for several testing modalities. CONCLUSIONS: PPS maculopathy causes considerable visual function degradation that is not fully captured with BCVA testing. There was good correlation between other measures of visual function and disease severity. These findings deepen our concern regarding this patient safety issue.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Lyons RJ, Brower J, Jain N, et al. Visual Function in Pentosan Polysulfate Sodium Maculopathy. Invest Ophthalmol Vis Sci. 2020. PMID: 33231621. doi:10.1167/iovs.61.13.33

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。